Allergan Plc's CEO Brent Saunders claimed that he is against fundamental shifts to the pharmaceutical company's business strategy on Monday, in order to stop its share price drop.
Allergan Plc's CEO Brent Saunders claimed that he is against fundamental shifts to the pharmaceutical company's business strategy on Monday, in order to stop its share price drop.